BNGO
Bionano Genomics, Inc.
+0.28 (+18.54%)1.79USD1.7M成交股數21.1M市值–本益比(近四季)0.7股價營收比+21.4%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 8.2M+21% | 6.7M+4% | 8.0M+31% | 7.4M-5% | 6.7M-23% | 6.5M-40% | 6.1M-35% | 7.8M-10% | 8.8M | 10.7M | 9.3M | 8.7M |
| 營業成本 | 3.9M | 3.4M | 4.6M | 4.0M | 3.3M | 3.5M | 14.5M | 5.2M | 5.9M | 8.3M | 6.6M | 6.4M |
| 毛利 | 4.3M+24% | 3.3M+11% | 3.4M-140% | 3.4M+30% | 3.5M+23% | 2.9M+20% | −8.4M-407% | 2.6M+12% | 2.8M | 2.4M | 2.7M | 2.3M |
| 毛利率 | 52.8% | 48.6% | 42.8% | 45.7% | 51.6% | 45.5% | -139.1% | 33.3% | 32.2% | 22.7% | 29.5% | 26.6% |
| 研發費用 | 3.0M | 3.1M | 3.2M | 2.8M | 2.9M | 2.4M | 4.7M | 6.8M | 9.8M | 11.7M | 13.8M | 14.6M |
| 銷售管理費用 | 8.5M | 8.0M | 8.7M | 9.1M | 8.3M | 9.0M | 9.5M | 11.6M | 19.1M | 15.0M | 24.9M | 26.9M |
| 營業利益 | −7.2M-7% | −7.9M-7% | −8.5M-81% | −8.5M-50% | −7.8M-75% | −8.5M-66% | −43.9M-61% | −17.0M-57% | −31.1M | −25.0M | −113M | −39.2M |
| 營業利益率 | -88.3% | -118.1% | -107.4% | -115.9% | -115.8% | -131.1% | -722.9% | -219.0% | -354.9% | -232.7% | -1,215.0% | -453.0% |
| 稅後淨利 | −7.4M+8% | −8.3M+168% | −7.9M-82% | −8.5M-48% | −6.9M-78% | −3.1M-93% | −44.2M-61% | −16.2M-58% | −31.4M | −43.9M | −113M | −38.9M |
| 淨利率 | -90.8% | -124.2% | -99.8% | -115.4% | -101.8% | -48.0% | -728.6% | -208.8% | -358.3% | -409.4% | -1,208.0% | -449.2% |
| 稀釋 EPS | -0.64-68% | -0.76-34% | -0.12-100% | -1.59-89% | -1.99-94% | -1.15-100% | -30.92+860% | -14.41+1062% | -35.75 | -402.91 | -3.22 | -1.24 |
| 稀釋股數 | 11.5M | 11.0M | 5.4M | 5.3M | 3.4M | 2.7M | 1.4M | 1.1M | 879K | 569K | 35.0M | 31.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.7M | 3.4M | 3.0M | 3.1M | 3.6M | 3.6M | 8.8M | 10.4M | 15.8M | 17.9M | 34.6M | 14.9M |
| 應收帳款 | 4.4M | 4.1M | 5.2M | 4.5M | 3.5M | 3.4M | 5.3M | 6.3M | 8.3M | 9.3M | 8.7M | 7.6M |
| 存貨 | 7.0M | 7.7M | 7.8M | 8.4M | 10.3M | 11.4M | 16.3M | 23.1M | 23.8M | 27.6M | 33.5M | 32.5M |
| 總資產 | 47.6M | 64.8M | 73.6M | 79.1M | 76.0M | 78.4M | 87.4M | 129M | 158M | 214M | 182M | 271M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 16.0M | 27.3M | 29.2M | 29.3M | 30.6M | 30.2M | 38.5M | 49.0M | 75.2M | 118M | 62.9M | 56.6M |
| 股東權益 | 31.6M | 37.5M | 44.4M | 49.8M | 45.4M | 48.2M | 48.9M | 80.3M | 82.8M | 96.2M | 119M | 215M |
| 負債比 | 33.6% | 42.2% | 39.6% | 37.0% | 40.3% | 38.5% | 44.1% | 37.9% | 47.6% | 55.2% | 34.6% | 20.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −5.7M+107% | – | – | – | −2.8M | – | – | −28.1M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 2.3M | – | – | – | 2.4M | – | – | 3.0M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 28.5M
| Reportable | 28.5M | 100.0% | -7.4% |
|---|
地區2025 年度 · 28.5M
| 歐洲中東非洲 | 14.1M | 49.5% | -0.9% |
|---|---|---|---|
| 美洲 | 12.2M | 42.7% | -10.8% |
| 亞太 | 2.2M | 7.8% | -23.3% |
產品／服務2025 年度 · 28.5M
| Consumable Revenue | 14.0M | 49.0% | +9.4% |
|---|---|---|---|
| Software Revenue | 6.4M | 22.5% | +3.5% |
| Instrument Revenue | 6.4M | 22.3% | -20.9% |
| Product And Service Other | 1.8M | 6.2% | -53.2% |
| 產品 小計 | 26.7M | 93.8% | -1.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 28.5M | -7.4% | −26.4M | -92.6% | -4.85 | – |
| FY2024 | 30.8M | -14.8% | −112M | -364.0% | -88.13 | – |
| FY2023 | 36.1M | +29.9% | −232M | -643.7% | -408.60 | – |
| FY2022 | 27.8M | +54.6% | −133M | -476.9% | -4.58 | – |
| FY2021 | 18.0M | +111.5% | −72.4M | -402.8% | -0.26 | – |
| FY2020 | 8.5M | -16.1% | −41.1M | -483.4% | -0.39 | −38.3M |
| FY2019 | 10.1M | -15.6% | −29.8M | -294.3% | -1.99 | −29.6M |
| FY2018 | 12.0M | – | −18.5M | -154.1% | -2.61 | −20.3M |